IL-17 plasma levels and erythrocyte sedimentation rate on oral candidiasis animal model
Downloads
Background: A study with female animal models is important because the system immune of females is remarkably different from the male because of interaction between sex hormone and immune system. Interleukin-17 (IL-17) plays an important role in immune response toward Candida albicans (C. albicans) infection and Erythrocyte Sedimentation Rate (ERS) is an easy and sensitive test to assess the inflammation. Purpose: This study aimed to evaluate C. albicans infection, analyse the IL-17 levels and ESR in a female animal model of oral candidiasis. Methods: Female Wistar rats were used as oral candidiasis animal model. The rats divided into three groups (pre-treatment group (P0), 5th-day post-treatment group (P1) and 8th-day post- treatment group (P1). Each group consists of six rats. After the adaptation period, the P0 was sacrificed. The drinking water of the P1 and P2 was added tetracycline HCl 500mg /1L. On the day before and after inoculation C. albicans, Methylprednisolone was injected. Ten minutes before inoculation with 0.3 ml C. albicans 9.4 x 107/mL, rats were sedated by CPZ 0.7 mg IM. The rats in P1 group were sacrificed after five days and in P2 were sacrificed eight days after inoculation. The IL-17 plasma levels measured by enzyme-linked immunosorbent assay (ELISA), decreased on the 5th day but not on the 8th-day post-treatment. The obtained data were analyzed by parametric and non-parametric tests according to normality and homogeneity of the data with p<0.05. Results: The colony forming unit (CFU) of C. albicans collected over the mouth on increased almost 8-fold and on 8th-day post-treatment almost 3-fold compared with pre-treatment. The ESR increased on the 8th day but not on the 5th-day post-treatment. Conclusion: The IL-17 level was decreased on the 3rd day, ESR increased on eight days after inoculation of C. albicans in female rats' model of oral candidiasis.
Downloads
Singh DK, Tóth R, Gácser A. Mechanisms of pathogenic candida species to evade the host complement attack. Front Cell Infect Microbiol. 2020; 10: 94. doi: https://doi.org/10.3389/fcimb.2020.00094
Seoane PI, May RC. Vomocytosis: What we know so far. Cell Microbiol. 2020; 22(2): 1–6. doi: https://doi.org/10.1111/cmi.13145
Patil S, Rao RS, Majumdar B, Anil S. Clinical appearance of oral candida infection and therapeutic strategies. Front Microbiol. 2015; 6: 1391. doi: https://doi.org/10.3389/fmicb.2015.01391
Nugraha AP, Ernawati DS, Parmadiati AE, Soebadi B, Prasetyo RA, Triyono EA, Sosiawan A. Study of drug utilization within an anti-fungal therapy for HIV/AIDS patients presenting oral candidiasis at UPIPI RSUD, Dr. Soetomo Hospital, Surabaya. J Int Dent Med Res. 2018; 11(1): 131–4. pdf: http://www.jidmr.com/journal/wp-content/uploads/2018/04/24D17_509_Diah_Savitri_Ernawati_Alexander_Nugraha13.pdf
Mensana MP, Ernawati DS, Nugraha AP, Soebadi B, Triyono EA, Husada D, Prasetyo RA, Utami SB, Sufiawati I. Oral candidiasis profile of the Indonesian HIV-infected pediatric patients at UPIPI Dr. Soetomo General Hospital, Surabaya, Indonesia. HIV AIDS Rev. 2018; 17(4): 272–7. doi: https://doi.org/10.5114/hivar.2018.80259
Nugraha AP, Ernawati DS, Parmadiati AE, Soebadi B, Triyono EA, Prasetyo RA, Utami SB, Sosiawan A. Prevalence of candida species in oral candidiasis and correlation with CD4+ count in HIV/AIDS patients at Surabaya, Indonesia. J Int Dent Med Res. 2018; 11(1): 81–5. pdf: http://www.jidmr.com/journal/wp-content/uploads/2018/04/15D17_459_Diah_Savitri_Ernawati_Alexander_Nugraha7.pdf
Sufiawati I, Pratiwi U, Wijaya I, Rusdiana T, Subarnas A. The relationship between Candida albicans colonization and oral hygiene in cancer patients undergoing chemotherapy. In: Materials Today: Proceedings. 2019. p. 2122–7. doi: https://doi.org/10.1016/j.matpr.2019.06.101
Martins N, Ferreira ICFR, Barros L, Silva S, Henriques M. Candidiasis: predisposing factors, prevention, diagnosis and alternative treatment. Mycopathologia. 2014; 177(5–6): 223–40. doi: https://doi.org/10.1007/s11046-014-9749-1
Seladi-Schulman J, Sethi S. About Candida albicans: Natural yeast and problematic infections. Medical News Today. 2018. Available from: https://www.medicalnewstoday.com/articles/322722. Accessed 2021 Sep 23.
Wicaksono S, Rezkita F, N. Wijaya F, Nugraha AP, Winias S. Ellagic acid: an alternative for antifungal drugs resistance in HIV/AIDS patients with oropharyngeal candidiasis. HIV AIDS Rev. 2020; 19(3): 153–6. doi: https://doi.org/10.5114/hivar.2020.98007
Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016; 16(10): 626–38. doi: https://doi.org/10.1038/nri.2016.90
Beery AK. Inclusion of females does not increase variability in rodent research studies. Curr Opin Behav Sci. 2018; 23: 143–9. doi: https://doi.org/10.1016/j.cobeha.2018.06.016
Ninomiya K, Hayama K, Ishijima SA, Maruyama N, Irie H, Kurihara J, Abe S. Suppression of inflammatory reactions by terpinen-4-ol, a main constituent of tea tree oil, in a murine model of oral candidiasis and its suppressive activity to cytokine production of macrophages in vitro. Biol Pharm Bull. 2013; 36(5): 838–44. doi: https://doi.org/10.1248/bpb.b13-00033
Takakura N, Sato Y, Ishibashi H, Oshima H, Uchida K, Yamaguchi H, Abe S. A novel murine model of oral candidiasis with local symptoms characteristic of oral thrush. Microbiol Immunol. 2003; 47(5): 321–6. doi: https://doi.org/10.1111/j.1348-0421.2003.tb03403.x
Sulistyani E, Dachlan YP, Putra ST. Enhancement of IL23-independendent IL17 level on intraperitoneal injection of Candida albicans cell wall in wistar male rat. J Int Dent Med Res. 2019; 12(4): 1368–71. pdf: http://www.jidmr.com/journal/wp-content/uploads/2019/12/21.D18_824_Erna_Sulistyani-1.pdf
Chaplin DD. Overview of the immune response. J Allergy Clin Immunol. 2010; 125(2 Suppl 2): S3-23. doi: https://doi.org/10.1016/j.jaci.2009.12.980
Qin Y, Zhang L, Xu Z, Zhang J, Jiang Y-Y, Cao Y, Yan T. Innate immune cell response upon Candida albicans infection. Virulence. 2016; 7(5): 512–26. doi: https://doi.org/10.1080/21505594.2016.1138201
CHROMagar. Chromogenic technology. 2022. Available from: https://www.chromagar.com/en/our-company/chromogenic-technology/. Accessed 2022 May 18.
University of IOWA. Anesthesia (Guideline). Vertebrate Animal Research website. 2020. p. 1. web: https://animal.research.uiowa.edu/iacuc-guidelines-anesthesia
Washington University in St. Louis. Animal euthanasia policy. USA; 2015. p. 1–4. pdf: https://research.wustl.edu/wp-content/uploads/2017/05/Euthanasia.pdf
Sparber F, LeibundGut-Landmann S. Interleukin-17 in antifungal immunity. Pathog (Basel, Switzerland). 2019; 8(2): 54. doi: https://doi.org/10.3390/pathogens8020054
Ocejo A, Correa R. Methylprednisolone. Treasure Island (FL): StatPearls Publishing; 2021. web: https://www.ncbi.nlm.nih.gov/books/NBK544340/
Conti HR, Gaffen SL. IL-17-mediated immunity to the opportunistic fungal pathogen Candida albicans. J Immunol. 2015; 195(3): 780–8. doi: https://doi.org/10.4049/jimmunol.1500909
van de Veerdonk FL, Gresnigt MS, Oosting M, van der Meer JWM, Joosten LAB, Netea MG, Dinarello CA. Protective host defense against disseminated candidiasis is impaired in mice expressing human interleukin-37. Front Microbiol. 2014; 5: 762. doi: https://doi.org/10.3389/fmicb.2014.00762
Hernández-Santos N, Gaffen SL. Th17 cells in immunity to Candida albicans. Cell Host Microbe. 2012; 11(5): 425–35. doi: https://doi.org/10.1016/j.chom.2012.04.008
Sokol CL, Luster AD. The chemokine system in innate immunity. Cold Spring Harb Perspect Biol. 2015; 7(5): a016303. doi: https://doi.org/10.1101/cshperspect.a016303
Zenobia C, Hajishengallis G. Basic biology and role of interleukin-17 in immunity and inflammation. Periodontol 2000. 2015; 69(1): 142–59. doi: https://doi.org/10.1111/prd.12083
Welch EZ, Anderson KL, Feldman SR. Interleukin 17 deficiency and implications in cutaneous and systemic diseases. J Dermatology Dermatologic Surg. 2015; 19(2): 73–9. doi: https://doi.org/10.1016/j.jdds.2015.03.004
Tishkowski K, Gupta V. Erythrocyte sedimentation rate. Treasure Island (FL): StatPearls Publishing; 2021. web: https://www.ncbi.nlm.nih.gov/books/NBK557485/
Copyright (c) 2022 Dental Journal (Majalah Kedokteran Gigi)
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
- Every manuscript submitted to must observe the policy and terms set by the Dental Journal (Majalah Kedokteran Gigi).
- Publication rights to manuscript content published by the Dental Journal (Majalah Kedokteran Gigi) is owned by the journal with the consent and approval of the author(s) concerned.
- Full texts of electronically published manuscripts can be accessed free of charge and used according to the license shown below.
- The Dental Journal (Majalah Kedokteran Gigi) is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License
